The RECORD Programme

Desirable Characteristics of an Anticoagulant

Mode of Action of ‘Xarelto’

Potential Health Economics Benefits of 'Xarelto'

Pooled Analysis of RECORD1, 2, and 3

Results of the Landmark RECORD Programme

Challenging the Burden of Mortality in ACS

Highly Effective Protection with Xarelto^®

One-Tablet, Once-Daily Xarelto^® Adds Simplicity to Stroke Prevention

Xarelto® (rivaroxaban): The First Single-Drug Solution for VTE Treatment (Summary)

Xarelto® (rivaroxaban) is Highly Effective in Treating Acute DVT and Preventing Recurrent VTE

Xarelto® (rivaroxaban): A Single-Drug Solution for the Treatment of DVT, and Prevention of Recurrent DVT and PE

Reassuring Safety Profile of Xarelto

Widening the Gap Between Risk and Benefit

History of Warfarin